320 related articles for article (PubMed ID: 18564392)
1. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
2. Calcium and magnesium levels during automated plateletpheresis in normal donors.
Das SS; Chaudhary R; Khetan D; Shukla JS; Agarwal P; Mishra RB
Transfus Med; 2005 Jun; 15(3):233-6. PubMed ID: 15943708
[TBL] [Abstract][Full Text] [Related]
3. Hypocalcemic symptoms during plateletpheresis using the COBE Spectra: a comparison of oral combination of 600mg calcium+300mg magnesium+100IU vitamin D3 vs. a 1000mg calcium in symptomatic donors.
Palfi M; Martinsson L; Sundström K
Transfus Apher Sci; 2007 Jun; 36(3):291-5. PubMed ID: 17613274
[TBL] [Abstract][Full Text] [Related]
4. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
[TBL] [Abstract][Full Text] [Related]
5. How to stabilize the level of ionized calcium and citrate during plateletpheresis.
Farrokhi P; Farahmand H; Bismuth A; Suarez C; Ducot B; Gillon MC; Debat P; Laskowski P; Pinon F
Vox Sang; 1998; 74(1):7-12. PubMed ID: 9481853
[TBL] [Abstract][Full Text] [Related]
6. Paired comparison of Gambro Trima Accel versus Baxter Amicus single-needle plateletpheresis.
Burgstaler EA; Winters JL; Pineda AA
Transfusion; 2004 Nov; 44(11):1612-20. PubMed ID: 15504167
[TBL] [Abstract][Full Text] [Related]
7. Severe citrate toxicity complicating volunteer apheresis platelet donation.
Bell AM; Nolen JD; Knudson CM; Raife TJ
J Clin Apher; 2007 Feb; 22(1):15-6. PubMed ID: 17111419
[TBL] [Abstract][Full Text] [Related]
8. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
Katz L; Palmer K; McDonnell E; Kabat A
Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
[TBL] [Abstract][Full Text] [Related]
9. A randomized comparison of plateletpheresis with the same donors using four blood separators at a single blood center.
Tenorio GC; Strauss RG; Wieland MJ; Behlke TA; Ludwig GA
J Clin Apher; 2002; 17(4):170-6. PubMed ID: 12494409
[TBL] [Abstract][Full Text] [Related]
10. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
Fontana S; Mordasini L; Keller P; Taleghani BM
Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
Picker SM; Radojska SM; Gathof BS
Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
[TBL] [Abstract][Full Text] [Related]
12. Tolerable infusion rate of citrate based on clinical signs and the electrocardiogram in conscious dogs.
Fukuda T; Toyoshima S; Nakashima Y; Koshitani O; Kawaguchi Y; Momii A
Clin Nutr; 2006 Dec; 25(6):984-93. PubMed ID: 16698131
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of platelets, white blood cells, and hematopoietic progenitor cells during high-yield plateletpheresis.
Fontana S; Rados L; Schmid P; Leibundgut EO; Taleghani BM
Transfusion; 2011 Sep; 51(9):2034-43. PubMed ID: 21438883
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and safety of triple dose platelet collection by apheresis.
Moog R
J Clin Apher; 2009; 24(6):238-40. PubMed ID: 19908304
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled study of intravenous magnesium supplementation during large-volume leukapheresis in healthy allogeneic donors.
Haddad S; Leitman SF; Wesley RA; Cecco S; Yau YY; Starling J; Rehak NN; Bolan CD
Transfusion; 2005 Jun; 45(6):934-44. PubMed ID: 15934992
[TBL] [Abstract][Full Text] [Related]
16. Automated regional citrate anticoagulation: technological barriers and possible solutions.
Szamosfalvi B; Frinak S; Yee J
Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
[TBL] [Abstract][Full Text] [Related]
17. A liquid calcium+vitamin D
Weinstein R; Haynes S; Zhao Y; Hickson E; Linden J; St Pierre P; Ducharme P; Sulmasy P; Graves M; Bailey JA; Welch L; Simard A; Vauthrin M; Greene M
J Clin Apher; 2018 Feb; 33(1):60-64. PubMed ID: 28653765
[TBL] [Abstract][Full Text] [Related]
18. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of citrate effects during plateletpheresis in normal donors.
Bolan CD; Greer SE; Cecco SA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2001 Sep; 41(9):1165-71. PubMed ID: 11552076
[TBL] [Abstract][Full Text] [Related]
20. Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial.
Heuft HG; Moog R; Fischer EG; Zingsem J;
Transfusion; 2013 Jan; 53(1):211-20. PubMed ID: 22612302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
